METHOTREXATE INJECTION USP
Google image searchProduct monograph
Active ingredient
methotrexate (methotrexate sodium), 25 MG/ML
DIN: 02182955
Dosage form(s): SOLUTION
Route(s) of administration: INTRACEREBROVENTRICULAR, INTRA-ARTERIAL, INTRAMUSCULAR, INTRATHECAL, INTRAVENOUS
Description: SINGLE USE VIALS. PRESERVATIVE-FREE
Schedule: Prescription
Company: PFIZER CANADA ULC
Date: 06-JUN-2017
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01B — ANTIMETABOLITES (ATC, ATC/DDD)
- L01BA — Folic acid analogues (ATC, ATC/DDD)
- L01BA01 — METHOTREXATE (ATC/DDD)
Pharmaceutical standard: USP
